120 related articles for article (PubMed ID: 16369373)
1. High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection.
Ruta SM; Matusa RF; Sultana C; Manolescu L; Kozinetz CA; Kline MW; Cernescu C
MedGenMed; 2005 Mar; 7(1):68. PubMed ID: 16369373
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of hepatitis B virus markers in romanian adolescents with human immunodeficiency virus infection.
Ruta SM; Matusa RF; Sultana C; Manolescu L; Kozinetz CA; Kline MW; Cernescu C
J Int AIDS Soc; 2005 Mar; 7(1):68. PubMed ID: 19825124
[TBL] [Abstract][Full Text] [Related]
3. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?
Thakur V; Guptan RC; Malhotra V; Basir SF; Sarin SK
J Assoc Physicians India; 2002 Nov; 50():1386-94. PubMed ID: 12583467
[TBL] [Abstract][Full Text] [Related]
5. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM
J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
[TBL] [Abstract][Full Text] [Related]
6. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
7. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
11. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
Kosi L; Reiberger T; Payer BA; Grabmeier-Pfistershammer K; Strassl R; Rieger A; Peck-Radosavljevic M
J Viral Hepat; 2012 Nov; 19(11):801-10. PubMed ID: 23043387
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Barrio E
Am J Gastroenterol; 2000 May; 95(5):1316-22. PubMed ID: 10811346
[TBL] [Abstract][Full Text] [Related]
13. The evolution of hepatitis B virus infection in children with symptomatic AIDS.
Cernescu C; Mătuşa F; Antipa C; Ruţă S
Rev Roum Virol; 1992; 43(1-2):7-11. PubMed ID: 1288642
[TBL] [Abstract][Full Text] [Related]
14. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P;
Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303
[TBL] [Abstract][Full Text] [Related]
15. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
[TBL] [Abstract][Full Text] [Related]
16. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
17. Serological markers for hepatitis B and treponemal infection among HIV carriers from Ethiopia.
Alkan ML; Maayan S; Belmaker I; Arbeli Y; Mani N; Ben-Yshai F
Isr J Med Sci; 1993; 29(6-7):390-2. PubMed ID: 8349459
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV.
Zoutendijk R; Zaaijer HL; de Vries-Sluijs TE; Reijnders JG; Mulder JW; Kroon FP; Richter C; van der Eijk AA; Sonneveld MJ; Hansen BE; de Man RA; van der Ende ME; Janssen HL
J Infect Dis; 2012 Sep; 206(6):974-80. PubMed ID: 22782950
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
Jaroszewicz J; Calle Serrano B; Wursthorn K; Deterding K; Schlue J; Raupach R; Flisiak R; Bock CT; Manns MP; Wedemeyer H; Cornberg M
J Hepatol; 2010 Apr; 52(4):514-22. PubMed ID: 20207438
[TBL] [Abstract][Full Text] [Related]
20. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
